India-EU FTA Could Reduce Drug Prices by Up to 20%, Transform Access to Biologics and Devices Susmita Roy29 Jan 2026 11:15 PM ISTNew Delhi: India's Free Trade Agreement (FTA) with the European Union is being projected as a major breakthrough for healthcare, with expectations of...
Lupin Expands GLP-1 Portfolio with Galenicum Semaglutide Deal sheeba farhat21 Jan 2026 7:01 PM ISTMumbai: Global pharmaceutical major Lupin Limited on Tuesday announced a licensing and supply agreement through its subsidiary Lupin Atlantis Holdings...
Novo Nordisk's Wegovy Gets UK Nod for Higher 7.2 mg Weekly Dose in Obesity Treatment sheeba farhat17 Jan 2026 4:06 PM ISTThe authorisation for the drug, chemically known as semaglutide, covers only patients with a body mass index of 30 or higher using the drug for weight...
Cipla Emerges as Domestic Contender in Anti-Obesity Market with Yurpeak Susmita Roy10 Jan 2026 10:06 PM ISTNew Delhi: India's third-largest drugmaker Cipla has made an early impact in the fast-expanding anti-obesity drug market, with its GLP-1 agonist brand...
From Launch to Leadership: Mounjaro Crosses Rs 333 Crore, Becomes India's Top-Selling Drug Farhat Nasim8 Nov 2025 5:06 PM ISTNew Delhi: Eli Lilly's diabetes and obesity drug Mounjaro (Tirzepatide) has become India's top-selling drug by value for October 2025, overtaking...
AACE Releases Adiposity-Based Chronic Disease (ABCD) 2025 Guidelines: Top Highlights from Consensus Statement Dr. Bhumika Maikhuri13 Oct 2025 12:45 PM ISTThe American Association of Clinical Endocrinology (AACE) has released its 2025 Consensus Statement, introducing a transformative approach to...
Medical Bulletin 15/Jul/2025 Dr. Bhumika Maikhuri15 July 2025 3:00 PM ISTHere are the top medical news for the day:Where, How, and Why You Exercise Affects Mental Health: StudyPublished in Medicine and Science in Sports and...
Tirzepatide Shakes Up Obesity Market as Mounjaro Records Rs 390 Mn Sales in June Farhat Nasim11 July 2025 3:05 PM ISTNew Delhi: In India's rapidly growing anti-obesity drug landscape, Mounjaro (tirzepatide), launched by Eli Lilly in March 2025, is quickly...
Delhi HC Flags Off-Label Use of Diabetes Drugs for Weight Loss, Seeks CDSCO Report Farhat Nasim3 July 2025 9:27 PM ISTNew Delhi: The Delhi High Court has directed the Central Drugs Standard Control Organisation (CDSCO) and the Drug Controller General of India (DCGI)...
Intas Gets CDSCO Panel Nod to Conduct Phase III Trial of Semaglutide Injection for Weight Management Parthika Patel17 Jun 2025 6:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has accepted the Bioequivalence (BE)...
Medical Bulletin 13/ August/ 2024 Dr. Garima Soni13 Aug 2024 3:00 PM ISTHere are the top medical news for the day:Appetite Control Through Brain Stimulation: A Groundbreaking Approach to Obesity Treatment?Metabolic...
Appetite Control Through Brain Stimulation: A Groundbreaking Approach to Obesity Treatment? Study Sheds Light Dr. Garima Soni13 Aug 2024 8:00 AM ISTMetabolic syndrome is a complex of multiple metabolic abnormalities, including obesity, high blood pressure, and high triglycerides, often caused by...
